LLS News Network

News and information from The Leukemia & Lymphoma Society

News Releases

LLS Applauds Approval of New Therapy for CLL Patients

Rye Brook, NY – April 12, 2016 – The approval of a new therapy for patients with a high-risk form of chronic lymphocytic leukemia (CLL) is welcome news for patients for whom there have been few other options, The Leukemia & Lymphoma Society (LLS) said today. The U.S. Food and Drug Administration has approved venetoclax (Venclexta ®) to treat patients with a rare subset of CLL in which a piece of chromosom...

LLS Recognizes Volunteers During National Volunteer Week

Rye Brook, NY, April 11, 2016 – Volunteer led, staff driven. As the world’s leading voluntary non-profit fighting blood cancers, The Leukemia & Lymphoma Society (LLS) has set the bar in defining volunteerism and demonstrating impact. During National Volunteer Week, April 10-16, 2016, LLS would like to thank all its volunteers making an impact in advocacy, policy and patient access.   “LLS has millio...

LLS Joins "Be Here Now" (The Andy Whitfield Story) Producers in Generating Awareness for Blood Cancers

Los Angeles, CA, April 4, 2016 – “Be Here Now” (The Andy Whitfield Story) and The Leukemia & Lymphoma Society (LLS) announced today their collaboration to spread awareness about the urgent need to find cures and ensure access to treatments for blood cancer patients. This news is timed to the U.S. theatrical release of this award winning feature documentary, about star, Andy Whitfield, of "Spartacu...

Walgreens and LLS Create New Approach to Support Cancer Patients in their Communities

Rye Brook, NY, and Deerfield, IL, March 16, 2016 - The Leukemia & Lymphoma Society (LLS) and Walgreen Co. today announced the launch of an innovative collaboration designed to further advance cancer therapies and address the changing treatment model facing patients with blood and other cancers. The collaboration, between LLS and Walgreens Specialty Pharmacy, builds on the heritage of Walgreens in serving its comm...


Meet the LLS Experts

Louis J. DeGennaro, Ph.D.
President and CEO

More than 25 years of research and drug development, and recognized as the key architect of LLS's cures and access agenda.

Lee Greenberger, Ph.D.,
Chief Scientific Officer

Over 25 years of experience in discovery and development of Oncology drugs. Leads planning and strategy for LLS research programs.

Andrew S. Coccari, Jr.,
EVP, Chief Product Officer

With more than 20 years of leadership in product development, marketing and sales experience in both consumer and wholesale industry spaces, Coccari is responsible for conception, development and implementation of all LLS fundraising campaigns.

Beatrice Abetti, LCSW, Director of Information Resource Center

Clinical social worker and leader of LLS’s Information Resource Center, providing highly specialized blood cancer information, education and support for patients and their families.

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: